Artemisinin derivative SM934 in the treatment of autoimmune and inflammatory diseases: therapeutic effects and molecular mechanisms
Crossref DOI link: https://doi.org/10.1038/s41401-022-00978-4
Published Online: 2022-09-01
Published Print: 2022-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tong, Xiao
Chen, Li
He, Shi-jun
Zuo, Jian-ping
Text and Data Mining valid from 2022-09-01
Version of Record valid from 2022-09-01
Article History
Received: 31 May 2022
Accepted: 7 August 2022
First Online: 1 September 2022
Competing interests
: The authors declare no competing interests.